SCHEMBL2483885

SCHEMBL2483885

COc1ccc(SCCCC(=O)N(C)c2nccc3ccccc23)cc1.COc1ccc([S+]([O-])CCCC(=O)N(C)Cc2cc(Cl)ccc2OC)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
RPLP1 P05386 1/20 0.33
RPLP0 P05388 1/20 0.33
RPS17 P08708 1/20 0.33
RPSA P08865 1/20 0.33
RPS2 P15880 1/20 0.33
RPL35A P18077 1/20 0.33
RPL7 P18124 1/20 0.33
RPL17 P18621 1/20 0.33
RPS4Y1 P22090 1/20 0.33
RPS3 P23396 1/20 0.33
RPS12 P25398 1/20 0.33
RPL13 P26373 1/20 0.33
RPL10 P27635 1/20 0.33
RPL12 P30050 1/20 0.33
RPL9; RPL9P7; RPL9P8; RPL9P9 P32969 1/20 0.33
RPL22 P35268 1/20 0.33
RPL4 P36578 1/20 0.33
RPS19 P39019 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2483956 0.87 PLA2G7 (0.31)
SCHEMBL2481064 0.84 PLA2G7 (0.33)
SCHEMBL3250338 0.82
SCHEMBL414720 0.81 RPLP1 (0.44) MAPTSMN1; SMN2RPLP1RPLP0RPS17
SCHEMBL411690 0.80 ALDH1A1 (0.46) MAPTSMN1; SMN2RPLP1RPLP0RPS17
SCHEMBL417286 0.80 SMN1; SMN2 (0.40) MAPTSMN1; SMN2ALDH1A1
SCHEMBL415251 0.78 ALDH1A1 (0.42) MAPTSMN1; SMN2MEN1KMT2ANPC1
SCHEMBL3252038 0.73 ALDH1A1 (0.31) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL2486849 0.72 TP53 (0.32) MAPTSMN1; SMN2RPLP1RPLP0RPS17
SCHEMBL416131 0.72 CNR2 (0.35) MAPTRPLP1RPLP0RPS17RPSA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376431-A1 NOVEL SUBSTITUTED ARYL DERIVATIVES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTICAL USES AS ANTI-HIV AGENTS LABORATOIRE BIODIM (FR) 2011-10-19 EP disclosed